Servicing Healthcare Professionals and CompaniesSchedule a Meeting
Toll Free Phone: 1-866-892-2032
We Accept:
Free Shipping After: $500

ALIDYA™

Brand: ALIDYA™

$139.00

Quantity Price
1 - 5 $139.00
6 - 10 $130.00
11 - 20 $128.00
21+ $126.00

Manufacturer: Ghimas S.p.A.
Active Substance(s) : POLYAMINO ACID GEL, D-GLUCOPYRANOSE, MANNITOL, SODIUM ETHYLENEDIAMINETETRAACETATE (EDTA)
Pack Size: 5 x 340mg Vials, 5 x 10ml Solvent
Accessories: Package insert

ALIDYA™ is an injectable device specifically indicated for the prevention and treatment of gynoid lipodystrophy (cellulite). Reduces appearance of cellulite and dimpled skin, improving overall look, and helps prevent cellulite from forming after treatment.

INFORMATION

Frequently Asked Questions

ALIDYA™ is a dense solution indicated for the correction of profilometric surface alterations associated with gynoid lipodystrophy. In the field of aesthetic medicine, ALIDYA™ is often used to improve body imperfections. This product is developed by Ghimas S.p.A., a pharmaceutical company headquartered in Casalecchio di Reno, Italy.

CE-marked: ALIDYA™ has obtained CE certification and is generally well-tolerated.
Scientifically developed formula: ALIDYA™ is developed by Dr. P. Motolese based on the most recent research on cellulite.

Package insert
5 – 340 mg vials with powder
5 – 10 ml vials with solvent

Polyamino acidic gel
a-D- (+) glucopyranose
1-4 glycosidic, ethylenediaminetetraacetic sodium
Amino acid buffer system (with bicarbonate- sodium
corrector andosmolarity regulator)

ALIDYA™ treatment usually involves minimal recovery time. Adverse reactions that occur after treatment are self-limiting and will disappear in several hours.

  • Due to prudential reasons, it is not advisable to use ALIDYA™ in individuals who have a history of serious allergy reactions (or anaphylaxis). Similarly, ALIDYA™ should not be used in patients with severe systemic (or organic) conditions such as autoimmune diseases.
  • Do not use this product in patients who are breastfeeding or pregnant. ALIDYA™ is contraindicated to be used in these patients.
  • For the twelve hours following treatment, patients should not use cosmetics on the treatment site. They should avoid exposing the treatment area to the sun, UV rays or other sources of direct heat.

  • Small superficial hematomas
  • Light to moderate redness at the injection site

  • Polyamino acidic gel
  • a-D- (+) glucopyranose
  • 1-4 glycosidic, ethylenediaminetetraacetic sodium
  • Amino acid buffer system (with bicarbonate- sodium corrector andosmolarity regulator)

ALIDYA™ is designed to deliver permanent results, although multiple treatments may be required to achieve optimal results.

CART (0)

No products in the cart.